Bausch + Lomb Corporation (BLCO) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
About Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO) stock trades at $17.47 with a market capitalization of $6.24B. The stock is valued at a negative price-to-earnings (P/E) ratio of -35.85, reflecting a net loss over the last twelve months, price-to-book of 0.96, price-to-sales of 1.15. Over the past 52 weeks the stock has ranged between $13.77 and $18.92, and currently trades 7.7% below its 52-week high.
On profitability, Bausch + Lomb Corporation generates a return on equity (ROE) of -2.67% (negative, reflecting a net loss), return on capital employed of 3.17%, an operating margin of 5.91%, a net profit margin of -3.21%.
Bausch + Lomb Corporation by the numbers, 2018–2025
Between 2018 and 2025 Bausch + Lomb Corporation reported revenue of $3.7B rising to $5.1B, a change of +39.2% across 8 years. Compounded, revenue has grown 8.4% a year over five years, 10.6% over three, 6.5% over the last twelve months. Net profit fell to $-360.0M.
Operating margin went from 11.3% in 2018 to 3.7% in 2025, a fall of 7.7 percentage points. The most recent net margin is -3.21%. On a trailing twelve-month basis to Jun '26, revenue is $5.3B and net profit $-171.0M.
Borrowings stand at $5.4B, cash from operations was $283.0M in the latest year, positive in 7 of the last 8.
Return on equity has averaged -2.5% over five years, and was -5.6% in the most recent year.
The share price itself has compounded at —% a year over five years, -8.5% over three, 21.9% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Bausch + Lomb Corporation (BLCO) — frequently asked questions
What is Bausch + Lomb Corporation (BLCO) stock price today?
Bausch + Lomb Corporation (BLCO) is currently trading at $17.47, up 0.23% today.
What is BLCO P/E ratio?
Bausch + Lomb Corporation's P/E ratio is -35.85. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is BLCO return on equity (ROE)?
Bausch + Lomb Corporation's return on equity (ROE) is -2.67%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Bausch + Lomb Corporation's market cap?
Bausch + Lomb Corporation has a market capitalization of $6.24B.
Does BLCO pay a dividend?
Bausch + Lomb Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does BLCO carry?
Bausch + Lomb Corporation has a debt-to-equity ratio of 0.80. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is BLCO's profit margin?
Bausch + Lomb Corporation reports a net profit margin of -3.21% — the share of revenue left after every cost, including tax and interest.
What sector is BLCO in?
Bausch + Lomb Corporation is classified under Healthcare, in the Medical - Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is BLCO listed on?
Bausch + Lomb Corporation trades on NYSE under the ticker BLCO.
What is BLCO's 52-week range?
Over the last year Bausch + Lomb Corporation has traded between $13.77 and $18.92.
Related Healthcare Stocks
Popular Stocks
Screens BLCO currently matches
On the figures above, Bausch + Lomb Corporation passes the filters for 7 of our ready-made screens, among them Low PB Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.